Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  C series |

---

|  |  |  |
| --- | --- | --- |
|  | C/2024/6433 | 4.11.2024 |

Judgment of the General Court of 18 September 2024 – Fidia farmaceutici v EUIPO – Vorwarts Pharma (HYALERA)

(Case T-497/23)
 [(1)](#ntr1-C_202406433EN.000101-E0001)

(EU trade mark - Opposition proceedings - Application for the EU word mark HYALERA - Earlier national word mark HYAL - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(C/2024/6433)

Language of the case: English

Parties

Applicant: Fidia farmaceutici SpA (Abano Terme, Italy) (represented by: R. Kunz-Hallstein, lawyer)

Defendant: European Union Intellectual Property Office (represented by: E. Śliwińska and D. Hanf, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Vorwarts Pharma sp. z o.o. (Białystok, Poland) (represented by: J. Aftyka, lawyer)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Fifth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 17 May 2023 (Case R 230/2023-5).

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Annuls the decision of the Fifth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 17 May 2023 (Case R 230/2023-5); |

|  |  |
| --- | --- |
| 2. | Orders EUIPO and Vorwarts Pharma sp. z o.o. to pay the costs. |

---

---

ELI: http://data.europa.eu/eli/C/2024/6433/oj

ISSN 1977-091X (electronic edition)

---

[Top](#document1)